{"acute kidney injury": 4.34, "adenocarcinoma": 23.95, "agranulocytosis": 3.72, "anaemia": 10.04, "blood creatinine increased": 3.7, "cytopenia": 8.6, "dermatitis": 2.27, "disease progression": 7.19, "drug eruption": 2.06, "drug intolerance": 3.05, "drug-induced liver injury": 2.98, "erysipelas": 7.42, "eyelid oedema": 7.67, "febrile bone marrow aplasia": 26.84, "febrile neutropenia": 9.86, "fluid retention": 2.37, "gastrointestinal toxicity": 18.78, "general physical health deterioration": 2.23, "glomerular filtration rate decreased": 2.53, "haematotoxicity": 55.91, "haemoglobin decreased": 2.33, "haemoptysis": 4.15, "hepatic function abnormal": 5.91, "hepatotoxicity": 10.58, "hypercreatininaemia": 71.11, "hypertransaminasaemia": 7.79, "hyponatraemia": 2.2, "interstitial lung disease": 3.13, "kidney fibrosis": 36.98, "lacrimation increased": 2.79, "leukopenia": 10.13, "liver injury": 4.56, "lung adenocarcinoma": 71.39, "lung adenocarcinoma stage iv": 109.66, "malignant neoplasm progression": 16.3, "metastases to bone": 2.78, "metastases to central nervous system": 4.92, "metastases to liver": 2.27, "metastases to lung": 3.84, "mouth ulceration": 2.33, "mucosal inflammation": 8.67, "myelosuppression": 55.48, "neoplasm progression": 4.9, "nephropathy toxic": 23.53, "neutropenia": 10.67, "neutropenic sepsis": 16.41, "neutrophil count decreased": 11.8, "non-small cell lung cancer": 21.49, "oedema peripheral": 2.1, "off label use": 2.31, "osteonecrosis of jaw": 3.67, "ototoxicity": 59.74, "pancytopenia": 13.47, "peripheral ischaemia": 13.06, "platelet count decreased": 6.9, "pleural effusion": 2.36, "pneumonia": 2.34, "pneumonitis": 5.99, "pneumothorax": 3.64, "proteinuria": 3.01, "pseudocellulitis": 1427.25, "pulmonary toxicity": 11.87, "red blood cell count decreased": 2.06, "renal failure": 2.86, "renal impairment": 5.43, "renal tubular necrosis": 21.43, "respiratory failure": 5.01, "scleroderma": 22.45, "sepsis": 2.37, "skin exfoliation": 2.22, "skin hyperpigmentation": 11.4, "skin toxicity": 15.03, "stomatitis": 2.21, "therapeutic product effect incomplete": 2.13, "therapeutic response decreased": 3.27, "therapy partial responder": 19.45, "thrombocytopenia": 7.27, "toxic epidermal necrolysis": 5.56, "toxicity to various agents": 3.39, "transaminases increased": 2.24, "treatment failure": 4.26, "tubulointerstitial nephritis": 9.3, "white blood cell count decreased": 9.83}